Phosphorus-based SAHA analogues as histone deacetylase inhibitors

Organic Letters

Volumn 5, Issue 17, 2003, Pages 3053-3056

  Kapustin, Galina V ^a   Fejér, György ^b,d   Gronlund, Jennifer L ^c   McCafferty, Dewey G ^c   Seto, Edward ^b   Etzkorn, Felicia A ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID DERIVATIVE; METAL CHELATE; PHOSPHORUS DERIVATIVE; PROTEINASE;

ARTICLE; CANCER CELL; CHELATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SYNTHESIS; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IC 50;

ANTINEOPLASTIC AGENTS; BACTERIAL PROTEINS; CELL NUCLEUS; ENZYME INHIBITORS; FEMALE; HELA CELLS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; INHIBITORY CONCENTRATION 50; ORGANOPHOSPHORUS COMPOUNDS; OVARIAN NEOPLASMS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0141855403     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol035056n     Document Type: Article

References (24)

1. (a) Weidle, U. H.; Grossmann, A. Anticancer Res. 2000, 20, 1471-1486.
2. (b) Marks, P.; Rifkind, R. A.; Richon, V. M.; Breslow, R.; Miller, T.; Kelly, W. K. Nature Rev. Cancer 2001, 1, 194-202.
3. (c) Grozinger, C. M.; Schreiber, S. L. Chem. Biol. 2002, 9, 3-16.
4. (a) Meinke, P. T.; Liberator, P. Curr. Med. Chem. 2001, 8, 211-235.
5. (b) Darkin-Rattray, S. J.; Gurnett, A. M.; Myers, R. W.; Dulski, P. M.; Crumley, T. M.; Allocco, J. J.; Cannova, C.; Meinke, P. T.; Colletti, S. L. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 13143-13147.
6. (c) Shestakova, E.; Bandu, M. T.; Doly, J.; Bonnefoy, E. J. Virol. 2001, 75, 3444-3452.
7. (d) Leoni, F.; Zaliani, A.; Bertolini, G.; Porro, G.; Pagani, P.; Pozzi, P.; Dona, G.; Fossati, G.; Sozzani, S.; Azam, T.; Buffer, P.; Fantuzzi, G.; Goncharov, I.; Kim, S. H.; Pomerantz, B. J.; Reznikov, L. L.; Siegmund, B.; Dinarello, C. A.; Mascagni, P. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 2995-3000.
8. (a) Richon, V. M.; Webb, Y.; Merger, R.; Sheppard, T.; Jursic, B.; Ngo, L.; Civoli, F.; Breslow, R.; Rifkind, R. A.; Marks, P. A. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5705-5708.
9. (b) Finnin, M. S.; Donigian, J. R.; Cohen, A.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.; Breslow, R.; Pavletich, N. P. Nature 1999, 401, 188-193.
10. (a) Nishino, N.; Powers, J. C. Biochemistry 1978, 17, 2846-2850.
11. (b) Kam, C.-M.; Nishino, N.; Powers, J. C. Biochemistry 1979, 18, 3032-3038.
12. Holmes, M. A.; Matthews, B. W. Biochemistry 1981, 20, 6912-6920.
13. (a) Nishino, N.; Powers, J. C. Biochemistry 1979, 18, 4340-4347.
14. (b) Jacobsen, N. E.; Bartlett, P. A. J. Am. Chem. Soc. 1981, 103, 654-657.
15. (c) Bartlett, P. A.; Marlowe, C. K. Biochemistry 1983, 22, 4618-4624.
16. (d) Bartlett, P. A.; Marlowe, C. K. Biochemistry 1987, 26, 8553-8561.
17. (e) Hanson, J. E.; Kaplan, A. P.; Bartlett, P. A. Biochemistry 1989, 28, 6294-6305.
18. (f) Morgan, B. P.; Scholtz, J. M.; Ballinger, M. D.; Zipkin, I. D.; Bartlett, P. A. J. Am. Chem. Soc. 1991, 113, 297-307.
19. (g) Bertenshaw, S. R.; Rogers, R. S.; Stern, M. K.; Norman, B. H.; Moore, W. M.; Jerome, G. M.; Branson, L. M.; McDonald, J. F.; McMahon, E. G.; Palomo, M. A. J. Med. Chem. 1993, 36, 173-176.
20. (h) Yiallouros, I.; Vassiliou, S.; Yiotakis, A.; Zwilling, R.; Stocker, W.; Dive, V. Biochem. J. 1998, 331, 375-379.
21. (i) Gall, A. L.; Ruff, M.; Kannan, R.; Cuniasse, P.; Yiotakis, A.; Dive, V.; Rio, M. C.; Basset, P.; Moras, D. J. Mol. Biol. 2001, 307, 577-586.
22. Campagne, J.-M.; Coste, J.; Jouin, P. J. Org. Chem. 1995, 60, 5214-5223.
23. Malachowski, W. P.; Coward, J. K. J. Org. Chem. 1994, 59, 7616-7624.
24. Carmen, A. A.; Rundlett, S. E.; Grunstein, M. J. Biol. Chem. 1996, 271, 15837-15844.